# Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine

> **NCT02785705** · PHASE3 · COMPLETED · sponsor: **Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control** · enrollment: 600 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** poliovirus vaccine

## Key facts

- **NCT ID:** NCT02785705
- **Lead sponsor:** Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2016-05-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785705, "Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02785705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*